Biotechnology Collaboration Agreements Analysis Report 2024: Access Upfront, Milestone, and Royalties Data for Deals Signed by the World's Leading Life Science Companies Since 2016

News provided by

Mar 13, 2024, 20:45 ET

DUBLIN, March 13, 2024 /PRNewswire/ -- The "Collaboration Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals. Fully revised and updated, the report provides details of collaboration deals from 2019 to 2024. The report provides access to collaboration deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaboration contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of collaboration dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in collaboration as well as a discussion on the merits of the type of deal. Chapter 3 provides an overview of the structure of collaboration deals.

Chapter 4 provides a review of the leading collaboration deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database. Chapter 5 provides a comprehensive listing of the top 25 most active collaboration dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of collaboration deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an in-depth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

The deal directory includes a comprehensive listing of all collaboration deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

Collaboration Deals in Biotechnology provides the reader with the following key benefits:

Understand deal trends since 2019
Browse collaboration deals
Benchmark analysis - identify market value of transactions
Financials terms - upfront, milestone, royalties
Directory of deals by company A-Z, therapy focus and technology type
Leading deals by value
Most active dealmakers
Identify assets and deal terms for each transaction
Access contract documents - insights into deal structures
Due diligence - assess suitability of your proposed deal terms for partner companies
Save hundreds of hours of research time

Analyzing contract agreements allows due diligence of:

What are the rights granted or optioned?
What rights are granted by the agreement?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are intellectual property rights handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What subcollaboration and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking
2.1. Introduction
2.2. Definition of collaboration deal
2.3. Trends in collaboration deals since 2019
2.3.1. Collaboration dealmaking by year, 2019-2024
2.3.2. Collaboration dealmaking by phase of development, 2019-2024
2.3.3. Collaboration dealmaking by industry sector, 2019-2024
2.3.4. Collaboration dealmaking by therapy area, 2019-2024
2.3.5. Collaboration dealmaking by technology type, 2019-2024
2.3.6. Collaboration dealmaking by most active company, 2019-2024
2.4. Reasons for entering into collaboration partnering deals
2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure
3.1. Introduction
3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals
4.1. Introduction
4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers
5.1. Introduction
5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory
6.1. Introduction
6.2. Collaboration deals with contracts 2019-2024

Deal directory
Deal directory - collaboration dealmaking by companies A-Z
Deal directory - collaboration dealmaking by therapy area
Deal directory - collaboration dealmaking by technology type

For more information about this report visit https://www.researchandmarkets.com/r/jpebdm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets